Safety and Efficacy of Tirofiban for Acute Ischemic Stroke Patients With Large Artery Atherosclerosis Stroke Etiology Undergoing Endovascular Therapy.

Conclusions: Tirofiban in AIS patients with LAA undergoing EVT is safe and may benefit the functional outcomes in anterior circulation and major stroke patients and showed a trend for reduced mortality. tirofiban endovascular therapy acute ischemic stroke large artery atherosclerosis safety and efficacy clinical outcome National Key Research and Development Program of China 10.13039/501100012166 2016YFC1301500 China Postdoctoral Science Foundation 10.13039/501100002858 2020-YJ-008 As shown in Table 1 , the median age of patients was 63 (55–71) years, 464 (71.5%) patients were male, and 244 (37.6%) had received tirofiban.

also in 53,322 other papers